# Homology-based Morphometry of Brain Atrophy: Methods and Applications

Preprint · Donato Quiccione, Mariam Pirashvili, Nathan Broomhead, Sean J. Fallon

- Archive id: arxiv:2604.24714
- Published: 2026-04-27
- arXiv: https://arxiv.org/abs/2604.24714
- Citations: 0
- Source URL: https://arxiv.org/abs/2604.24714
- PDF: https://arxiv.org/pdf/2604.24714
- Provenance: arxiv

## Abstract

Understanding the structure of the brain, and how it changes with time and disease, is a core goal of structural neuroimaging. Contemporary approaches to structural brain analysis are dominated by voxel-wise, mass-univariate methods such as voxel-based morphometry (VBM). However, these techniques require images to be normalized to a standard template, which can obscure subject-specific geometric features. Normalization to a common stereotactic space can also be problematic when comparing groups with substantial brain pathology, lesions, or other anatomical abnormalities. Here, we introduce two complementary pipelines based on persistent homology (PH), a tool from topological data analysis, to quantify multiscale geometric features of structural T1-weighted MRI scans. Pipeline 1 quantifies regional thinning by applying the Euclidean distance transform to tissue masks in a slice-wise manner. Pipeline 2 uses \\(α\\)-filtrations to measure structural similarity between pairs of scans, capturing sulcal widening and ventricular enlargement. Synthetic experiments with controlled induced lesions showed that Pipeline 1 is best suited to between-subject analyses, whereas Pipeline 2 is better suited to within-subject designs. Applied to real-world data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), Pipeline 1 separated Alzheimer's disease (AD) from cognitively normal (CN) participants using single-modality T1-weighted MRI without nonlinear registration (ROC-AUC = 0.895), with peak effects localized to medial temporal regions. Pipeline 2 captured disease-related longitudinal change, with follow-up scans remaining closest to their own baselines and AD subjects showing greater short-interval change than CN subjects. Together, these pipelines provide interpretable topological biomarkers for cross-sectional group comparisons and longitudinal tracking.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.